Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle plk'

Search results for: 'research area cell cycle plk'

Items 61-70 of 126

Page
per page
  1. KU-0060648
    A1769 KU-0060648
     1 Citation
    Target: PI3K|DNA-PK
    Summary: Dual DNA-PK/PI3-K inhibitor, ATP-competitive
  2. AZD1480
    A4137 AZD1480
    Target: JAK
    Summary: JAK2 inhibitor,ATP-competitive and novel
      insoluble in H2O; ≥93.8 mg/mL
  3. Lomeguatrib
    A1912 Lomeguatrib
    Target: O6-methylguanine-DNA-methyl-transferase (MGMT)
    Summary: MGMT inhibitor
      ≥50 mg/mL
  4. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL
  5. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  6. MG-132
    A2585 MG-132
     26 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor, Cell permeable, reversible
      ≥23.78 mg/mL
  7. NSC 3852
    A4496 NSC 3852
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.35 mg/mL
  8. LY2090314
    A3570 LY2090314
    Target: GSK-3
    Summary: Potent GSK-3 inhibitor
      insoluble in H2O; ≥91 mg/mL
  9. Vatalanib
    A3969 Vatalanib
     1 Citation
    Target: VEGFR
    Summary: VEGFR-1/-2 inhibitor,cell-permeable
      ≥16.85 mg/mL
  10. Panobinostat (LBH589)
    A8178 Panobinostat (LBH589)
     10 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in H2O; insoluble in EtOH; ≥17.47 mg/mL

Items 61-70 of 126

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Animal Experiments Remove This Item
  2. Related Disease Cancer Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 124item
  2. Natural Products 1 item
Specificity
  1. Selective 92item
Reversibility
  1. Reversible 10item
  2. Irreversible 4item
Target
  1. Caspases 2item
  2. Cyclin-Dependent Kinases 13item
  3. Proteasome 3item
  4. Histone Deacetylases (HDACs) 7item
  5. Inhibitor of apoptosis proteins (IAP) 1 item
  6. Akt 1 item
  7. Bcl-2 2item
  8. PI3K 2item
  9. Raf 1 item
  10. Aurora Kinases 2item
  11. Glycoproteins 1 item
  12. MDM2 1 item
  13. EZH2 1 item
  14. AP-1 1 item
  15. FLT3 1 item
  16. GSK-3 2item
  17. LPA Receptors 1 item
  18. P-glycoprotein (P-gp) 3item
  19. PLK 6item
  20. Chk 3item
  21. VEGFR 4item
  22. PDGFR 2item
  23. c-Kit 1 item
  24. Bromodomain-containing proteins(BRDs) 1 item
  25. p38 1 item
  26. MEK 1 item
  27. PORCN 1 item
  28. DOT1L 1 item
  29. FGFR 1 item
  30. Smoothened 2item
  31. Ras 1 item
  32. Trk Receptors 1 item
  33. STAT 3item
  34. Microtubules/Tubulins 4item
  35. EGFR 5item
  36. Hedgehog 1 item
  37. ROCK 1 item
  38. JAK 4item
  39. p300 1 item
  40. DNA-PK 1 item
  41. HSP90 1 item
  42. TNKS 1 item
  43. ErbB 2item
  44. DNA Methyltransferases 1 item
  45. BMI-1 1 item
  46. PKC 3item
  47. Lyn 1 item
  48. SGLT 1 item
  49. RAD51 1 item
  50. ALK 1 item
  51. Sphingosine kinases (SphKs) 1 item
  52. PKA 1 item
  53. Autophagy 2item
  54. ATM/ATR 2item
  55. Farnesyl Diphosphate Synthases 1 item
  56. MAGL 1 item
  57. MNK 1 item
  58. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  59. p70 rsk 1 item
  60. Microtubule/Tubulin 1 item
  61. p53-MDM2 interaction 1 item
  62. KDR 1 item
  63. p53 2item
  64. insulin 1 item
  65. Ub-conjugating enzyme (E2) complex 1 item
  66. Smoothened receptor 1 item
  67. HDM2 ubiquitin ligase 1 item
  68. Antibiotic 1 item
  69. DNA Alkylating 1 item
  70. GLI 1 item
  71. Ribonucleotide Reductases 1 item
  72. Flk1 1 item
  73. RHA 1 item
  74. Bcl-w 1 item
  75. PPK 1 item
  76. c-Syk 1 item
  77. CDK1/CyclinB 1 item
  78. Bax 1 item